• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Allysta Pharma Announces Completion of Enrollment in Ph2b/3 Trial (OASIS-1)

    ACCESSWIRE

    Allysta Announces Initiation of Dosing in OASIS-1 Phase 2b/3 Clinical Trial

    ACCESSWIRE

    Allysta Pharma Announces Start of Phase 1 Clinical Trial of ALY688-SR

    ACCESSWIRE

    Allysta Pharmaceuticals, Inc. Announces Positive Preclinical Data

    ACCESSWIRE

    Allysta nnounces Positive Results from its Phase 1/2a Clinical Trial of ALY688

    ACCESSWIRE

    Allysta Pharmaceuticals, Inc. Doses First Patient with ALY688 Solution

    PRESS RELEASE

    Allysta Pharmaceuticals, Inc. Doses First Patient with ALY688 Solution

    PRESS RELEASE

    Allysta Pharmaceuticals, Inc. Doses First Patient with ALY688 Solution

    PRESS RELEASE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.